KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,675,472 | +5.7% | 117,892 | +7.0% | 1.26% | -12.2% |
| Q2 2023 | $12,936,541 | +89.7% | 110,192 | +29.4% | 1.44% | +103.7% |
| Q1 2023 | $6,819,431 | -54.3% | 85,179 | -54.7% | 0.71% | -67.0% |
| Q4 2022 | $14,910,551 | +3.2% | 188,217 | -9.2% | 2.14% | +8.9% |
| Q3 2022 | $14,451,000 | +2.6% | 207,332 | -3.3% | 1.96% | -10.6% |
| Q2 2022 | $14,083,000 | -26.8% | 214,482 | -25.9% | 2.20% | -11.6% |
| Q1 2022 | $19,252,000 | +20.5% | 289,337 | +26.7% | 2.48% | +55.2% |
| Q4 2021 | $15,979,000 | +143.8% | 228,437 | +82.0% | 1.60% | +56.7% |
| Q3 2021 | $6,554,000 | +42.7% | 125,529 | +85.9% | 1.02% | +44.6% |
| Q2 2021 | $4,592,000 | -64.3% | 67,529 | -59.5% | 0.71% | -69.5% |
| Q1 2021 | $12,854,000 | +1956.6% | 166,844 | +1500.7% | 2.32% | +2724.4% |
| Q4 2020 | $625,000 | – | 10,423 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |